Venture Capital in USA – Johnson & Johnson Development Corporation

Johnson & Johnson Development Corporation (JJDC) is the venture capital subsidiary of Johnson & Johnson. JJDC makes private equity investments in venture funded health care companies. Portfolio companies include those in the fields of pharmaceuticals, biotechnology, medical devices, diagnostics and consumer products. JJDC also leads and manages internal investments in selected promising technologies. Therapeutic Area Preferences: Anti-Infectives, Cardiovascular, Cell Therapy, Central Nervous System/Neurology, Immune-Mediated Inflammatory Diseases, Micro-Electro-Mechanical Systems (MEMS), Metabolic (Diabetes, Obesity, Hyperlipidemia), Oncology, Ophthalmology, Pain, Spine, and Tissue Engineering. Geographical Preferences: North America, Europe, and Israel. Funding Stage Preferences: Start Up, First and Second Round. Initial Investment Size: Up to $5 million © Johnson & Johnson Development Corporation